Bifidobacterium adolescentis – BA02 (DSM 18351, formerly ALB 1)
Constipation • Intestinal transit
Bifidobacterium
Bifidobacterium animalis subsp. lactis – BA05 (DSM 18352)
Production of folic acid • Rebalance of intestinal microbiota
Bifidobacterium animalis subsp. lactis – Bb1 (DSM 17850)
Under worldwide exclusive license from BIOMAN for nutraceutical and pharma applications Organic zinc from probiotic strain allergen free with High Bioavailability:Normal function of the immune system • Normal DNA synthesis and cell division • Protection of DNA, proteins and lipids from oxidative damage • Maintenance of normal bone • Normal cognitive function • Fertility and …
Bifidobacterium animalis subsp. lactis – Bb1 (DSM 17850) Read More »
Bifidobacterium animalis subsp. lactis – BS01 (LMG P-21384)
Constipation • Intestinal transit • Reduction of gastrointestinal discomfort • Leaky gut • Strengthening of natural defences and natural immunity • Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) production
Bifidobacterium animalis subsp. lactis – BS07 (MB 243)
Cardiovascular health • Cholesterol lowering
Bifidobacterium bifidum – BB06 (MB 107)
Cardiovascular health • Cholesterol lowering
Bifidobacterium bifidum – MB109 (DSM 23731)
Cardiovascular health • Cholesterol lowering
Bifidobacterium breve – BR03 (DSM 16604)
Constipation • Intestinal transit • Anti-inflammatory • Reduction of gastro-intestinal discomfort • Inhibition of pathogenic E. coli • Restoration of a better dietary ω-6/ω-3 balance • Conjugated linoleic acids (CLA) production • Prospective use in the treatment of obesity • Cystitis • Inhibition of E. coli • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction …
Bifidobacterium breve – B632 (DSM 24706)
Inhibition of pathogens E. coli and Enterobacteriaceae
Bifidobacterium breve – MB113 (DSM 23732)
Cardiovascular health • Cholesterol lowering
Bifidobacterium infantis – BI02 (DSM 24687, formerly MB287)
Cardiovascular health • Cholesterol lowering
Bifidobacterium lactis – BS05 (DSM 23032)
Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) production
Bifidobacterium lactis – MB2409 (DSM 23733)
Cardiovascular health • Cholesterol lowering
Bifidobacterium longum – W11 (LMG P-21586)
Reduction of gastro-intestinal discomfort related to IBS • Rebalance of intestinal microbiota • Non-transmissible rifamycins resistance • Production of Exopolysaccharides • Hepatic encephalopathy
Bifidobacterium longum – BL03 (DSM 16603)
Constipation • Intestinal transit • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
Bifidobacterium longum – 04 (DSM 23233)
Restoration of a better dietary ω-6/ω-3 balance • Conjugated linoleic acids (CLA) production • Prospective use in the treatment of obesity • Cholesterol management
Bifidobacterium lactis Lafti® B94
The probiotic strain Bifidobacterium lactis Lafti® B94 has been specifically documented in the area of gut health. It benefits from a strong body of clinical evidence, supported by in vitro and in vivo documentation of its modes of action. A converging body of clinical evidence: digestive comfort Gut transit in all population groups (infants from birth, children, adolescents, adults): Bifidobacterium animalis …
Bifidobacterium animalis subsp. lactis BL050 (DSM 25566)
Bifidobacterium animalis subsp. lactis BL050 (DSM 25566), developed by SynBalance.Gastrointestinal Health • Urogenital health • Metabolic Health• Immune prevention
Bifidobacterium longum subsp. longum BLG240 (LMG P-29511)
Bifidobacterium longum subsp. longum BLG240 (LMG P-29511), developed by SynBalance.Gastrointestinal Health • Immune prevention
Bifidobacterium bifidum BBF210
Bifidobacterium bifidum BBF210 (LMG P-29508), developed by SynBalance.Gastrointestinal Health
Bifidobacterium longum subsp. infantis BI221 (LMG P-29639)
Bifidobacterium longum subsp. infantis BI221 (LMG P-29639), developed by SynBalance.Gastrointestinal Health • Immune prevention
Bifidobacterium breve BB077 (LMG P-30157)
Bifidobacterium breve BB077 (LMG P-30157), developed by SynBalance.Gastrointestinal Health • Cognitive function• Immune prevention
